FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Jeitner

Research Profile

Chemicals & Drugs

Concepts & Ideas

Physiology

Disorders

Anatomy

Living Beings

Mouse

Phenomena

Magnetic Resonance Spectroscopy

Co-author Network

Publications

TOP 3
Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
γ-Glutamylamines and neurodegenerative diseases.
Irving H Gomolin; Candace Smith; Thomas M Jeitner
Donepezil dosing strategies: pharmacokinetic considerations.
Irving H Gomolin; Candace Smith; Thomas M Jeitner
Cholinesterase inhibitors: applying pharmacokinetics to clinical decision making.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Jeitner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
γ-Glutamylamines and neurodegenerative diseases.
Amino acids 2013;44(1):129-42.
2011: Irving H Gomolin; Candace Smith; Thomas M Jeitner
Donepezil dosing strategies: pharmacokinetic considerations.
Journal of the American Medical Directors Association 2011;12(8):606-8.
2011: Irving H Gomolin; Candace Smith; Thomas M Jeitner
Cholinesterase inhibitors: applying pharmacokinetics to clinical decision making.
The American journal of geriatric pharmacotherapy 2011;9(4):259-63.
2010: Irving H Gomolin; Candace Smith; Thomas M Jeitner
Once-daily memantine: pharmacokinetic and clinical considerations.
Journal of the American Geriatrics Society 2010;58(9):1812-3.
2009: John Pinto; Tetyana Khomenko; Sandor Szabo; Gordon D McLaren; Travis T Denton; Boris Krasnikov; Thomas M Jeitner; Arthur J L Cooper
Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(28):3434-41.
2009: Thomas M Jeitner; John Pinto; Boris Krasnikov; Mark Horswill; Arthur J L Cooper
Transglutaminases and neurodegeneration.
Journal of neurochemistry 2009;109 Suppl 1():160-6.
2008: Thomas M Jeitner; Wayne R Matson; John E Folk; John P Blass; Arthur J L Cooper
Increased levels of gamma-glutamylamines in Huntington disease CSF.
Journal of neurochemistry 2008;106(1):37-44.
2007: Matthew Milkevitch; Thomas M Jeitner; Nancy J Beardsley; Edward Delikatny
Lovastatin enhances phenylbutyrate-induced MR-visible glycerophosphocholine but not apoptosis in DU145 prostate cells.
Biochimica et biophysica acta 2007;1771(9):1166-76.
2005: John Pinto; Jeremy M van Raamsdonk; Blair R Leavitt; Michael R Hayden; Thomas M Jeitner; Howard T Thaler; Boris Krasnikov; Arthur J L Cooper
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.
Journal of neurochemistry 2005;94(4):1087-101.
2005: Thomas M Jeitner; Edward Delikatny; Jenny Ahlqvist; Hugh Capper; Arthur J L Cooper
Mechanism for the inhibition of transglutaminase 2 by cystamine.
Biochemical pharmacology 2005;69(6):961-70.
2005: Thomas M Jeitner; Hui Xu; Gary Gibson
Inhibition of the alpha-ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono-N-chloramine.
Journal of neurochemistry 2005;92(2):302-10.
2003: Arthur J L Cooper; Boris Krasnikov; Etsuo Okuno; Thomas M Jeitner
L-alanine-glyoxylate aminotransferase II of rat kidney and liver mitochondria possesses cysteine S-conjugate beta-lyase activity: a contributing factor to the nephrotoxicity/hepatotoxicity of halogenated alkenes?
The Biochemical journal 2003;376(Pt 1):169-78.
2002: Alpaslan Dedeoglu; James K Kubilus; Thomas M Jeitner; Samantha Matson; Mikhail B Bogdanov; Neil W Kowall; Wayne R Matson; Arthur J L Cooper; Rajiv R Ratan; M Flint Beal; Steven M Hersch; Robert J Ferrante
Therapeutic effects of cystamine in a murine model of Huntington's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(20):8942-50.
2002: Gary Gibson; Hui Zhang; Hui Xu; Larry C H Park; Thomas M Jeitner
Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme.
Biochimica et biophysica acta 2002;1586(2):177-89.
2002: Soo-Youl Kim; Thomas M Jeitner; Peter M Steinert
Transglutaminases in disease.
Neurochemistry international 2002;40(1):85-103.
2002: Arthur J L Cooper; Thomas M Jeitner; Vittorio Gentile; John P Blass
Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?
Neurochemistry international 2002;40(1):53-67.
2002: Arthur J L Cooper; Thomas M Jeitner; John P Blass
The role of transglutaminases in neurodegenerative diseases: overview.
Neurochemistry international 2002;40(1):1-5.
2001: Thomas M Jeitner; Mikhail B Bogdanov; Wayne R Matson; Yevgeny Daikhin; Marc Yudkoff; J E Folk; L Steinman; Susan E Browne; M Flint Beal; John P Blass; Arthur J L Cooper
N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.
Journal of neurochemistry 2001;79(5):1109-12.
2001: Thomas M Jeitner; Hans-Lothar Fuchsbauer; John P Blass; Arthur J L Cooper
A sensitive fluorometric assay for tissue transglutaminase.
Analytical biochemistry 2001;292(2):198-206.
1998: Thomas M Jeitner; Edward Delikatny; W A Bartier; H R Capper; N H Hunt
Inhibition of drug-naive and -resistant leukemia cell proliferation by low molecular weight thiols.
Biochemical pharmacology 1998;55(6):793-802.
1997: S K Roman; Thomas M Jeitner; R Hancock; Wendy A Cooper; Darryl C Rideout; Edward Delikatny
Induction of magnetic resonance-visible lipid in a transformed human breast cell line by tetraphenylphosphonium chloride.
International journal of cancer. Journal international du cancer 1997;73(4):570-9.
1996: Edward Delikatny; S K Roman; R Hancock; Thomas M Jeitner; C M Lander; D C Rideout; Carolyn E Mountford
Tetraphenylphosphonium chloride induced MR-visible lipid accumulation in a malignant human breast cell line.
International journal of cancer. Journal international du cancer 1996;67(1):72-9.
1996: F J Renton; Thomas M Jeitner
Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators.
Biochemical pharmacology 1996;51(11):1553-61.
1996: Thomas M Jeitner; F J Renton
Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine.
Cancer letters 1996;103(1):85-90.
1996: Edward Delikatny; C M Lander; Thomas M Jeitner; R Hancock; Carolyn E Mountford
Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response.
International journal of cancer. Journal international du cancer 1996;65(2):238-45.
1995: Sherilyn Goldstone; J C Fragonas; Thomas M Jeitner; Nicholas H Hunt
Transcription factors as targets for oxidative signalling during lymphocyte activation.
Biochimica et biophysica acta 1995;1263(2):114-22.
1994: Thomas M Jeitner; C L Kneale; Richard Christopherson; Nicholas H Hunt
Thiol-bearing compounds selectively inhibit protein kinase C-dependent oxidative events and proliferation in human T cells.
Biochimica et biophysica acta 1994;1223(1):15-22.
1994: L I Huschtscha; Thomas M Jeitner; C E Andersson; W A Bartier; M H Tattersall
Identification of apoptotic and necrotic human leukemic cells by flow cytometry.
Experimental cell research 1994;212(1):161-5.